Authoritative, Comprehensive, and Free Medical Cannabis Research
Dr. Miller 
The current state of medical marijuana access in the United States is a contentious issue. For years, debates have raged over its efficacy as a viable medical treatment option, and while some states have taken steps to legalize it, many others continue to restrict access or even criminalize its use altogether. However, recent research suggests that this lack of access …
Recent scientific research has revealed that cannabidiol (CBD) may not have the ability to reduce the side effects associated with tetrahydrocannabinol (THC). The findings, which were published in the journal Addiction, indicate that CBD may play a more limited role than previously thought in reducing the adverse effects of THC. CBD has become increasingly popular in recent years, with many …
A new study published in the Journal of the American Medical Association (JAMA) Psychiatry has concluded that there is “no statistically significant increase” in psychosis-related diagnoses in states that have legalized marijuana compared to those that continue to criminalize cannabis. The research team, led by scientists from Stanford University, the University of Pennsylvania and the U.S. Department of Veterans Affairs …
The Substance Abuse and Mental Health Services Administration (SAMHSA) recently issued an advisory regarding the potential harms, side effects, and unknowns associated with the use of Cannabidiol (CBD). This comes as CBD is gaining in popularity among Americans, with an estimated 270,000 retailers across the country selling various CBD-infused products, including topicals, fabric, food, and beverages. SAMHSA underscored the need …
The therapeutic benefits of cannabigerolic acid (CBGA) have gained increased attention in recent years, with more and more studies being conducted to assess its efficacy as a potential treatment for a range of health conditions. CBGA is one of the most abundant compounds found in the Cannabis sativa plant, and it has been identified as the precursor molecule for the …
Hi, I’m Dr. Paul Miller MD, a Board Certified Neurologist with 28 years of experience in the medical field. I graduated from the Johns Hopkins University School of Medicine in 1995 and have since dedicated my career to advancing our understanding and treatment of neurological disorders. Through my research and practice, I am committed to finding new and innovative ways …